Third European Congress of Virology

1 - 5 September 2007, CCN CongressCenter Nürnberg · Germany

bullet point   Poster Session III


We suggest to use the query function ('strg/ctrl' and 'F') and entering the abstract number

Reference Abstract authors Affiliation Abstract title Workshop Poster
number number
of abstract
Workshop 17
viro00133 * Igor Mazur (1), Anhlan Darisuren (1), David Mitzner (2), Ludmilla Wixler (1), Ulrich Schubert (2), Stephan Ludwig (1) (1) WWU, Institute of Molecular Virology, Münster, Germany; (2) University of Erlangen-Nürnberg, Institute of Clinical and Molecular Novel functions of the influenza virus PB1-F2 protein Negative Strand RNA Viruses II NII001
Virology, Erlangen, Germany
viro00412 * Rocio Coloma (1), Jaime Martín-Benito (1), José María Valpuesta (1), José Luis Carrascosa (1), (1) Centro Nacional de Biotecnología, Madrid, Spain Structure of an influenza virus recombinant ribonucleoprotein (RNP) Negative Strand RNA Viruses II NII002
Juan Ortín (1)
viro00420 * Nuria Jorba (1), Silvia Juarez (1), Eva Torreira (1), Pablo Gastaminza (1), Estela Area (1), Juan Pablo Albar (1), Juan Ortín (1) Centro Nacional de Biotecnología, Madrid, Spain Proteomic Analysis of Intracellular Complexes Formed By the RNA Polymerase of Influenza Virus Negative Strand RNA Viruses II NII003
(1)
viro00496 M. Pancratius (1), W. Ma (2), * S. Pleschka (1) (1) Justus-Liebig-University, Institute for Medical Virology, Giessen, Germany; (2) National Animal The Secondary Structure of the 5’-and 3’-End of Borna Disease Virus Genomic Negative Strand RNA Viruses II NII004
Disease Centre, B15, RNA Can Fold Into
Ames, USA “Panhandle” and
“Cork-Screw”
Configuration
viro00552 * Marius Ruf (1), Paul Verbruggen (1), Gjon Blakqori (1), Sybille Haid (1), Martin (1) University of Freiburg, Department of Virology, Freiburg, Germany; (2) GSF Dysregulation of Host Cell RNA Polymerase II by the La Crosse Virus Negative Strand RNA Viruses II NII005
Heidemann (2), Dirk Eick (2), Friedemann Weber (1) Research Center, Institute of Clinical Molecular Biology and Tumor Genetics, Virulence Factor NSs
München, Germany
viro00556 * Julia Kessler (1), Jacques R Kremer (1), (1) LNS, Institute of Immunology, IFN-[alpha]/[beta] signaling in MV Negative Strand RNA NII006
Claude P Muller (1) Luxembourg, Luxembourg infected PBMCs Viruses II
viro00591 * Anika Kern (1), Stefan Finke (2), Karl-Klaus Conzelmann (1) (1) Max von Pettenkofer-Institute & Gene Center, LMU Munich, Germany; (2) Friedrich-Loeffler- The Matrix Protein of Rabies Virus and its Functions in Viral Assembly and Budding Negative Strand RNA Viruses II NII007
Institute, Insel Riems,
Germany
viro00602 * Kirsi Jääskeläinen (1), Pasi Kaukinen (2), Ekaterina Minskaya (3), Angelina Plyusnina (1) Haartman Institute, Department of Virology, Helsinki, Finland; (2) National Public Health Tula and Puumala hantavirus NSs proteins Negative Strand RNA Viruses II NII008
(1), Olli Vapalahti (1), Richard Elliott (4), Friedemann Weber (5), Antti Vaheri (1), Institute, Department of Viral Diseases and Immunology, Helsinki, Finland; (3) School of
Alexander Plyusnin (1) Biomedical Sciences, Queen\\\\\\\'s University Belfast, Medical Biology Centre, Belfast, United
Kingdom; (4) School of Biology, University of St
Andrews, Centre for
Biomolecular Sciences,
St Andrews, United
Kingdom; (5) Institut für Medizinische
Mikrobiologie und
Hygiene, Abteilung Virologie, Freiburg, Germany
viro00605 A. Vidy (1), J. El Bougrini (2), M. Chelbi-Alix (2), * D. Blondel (1) (1) CNRS UMR2472, 91198, Gif sur Yvette, France; (2) CNRS FRE 2944, 94801, Villejuif, The nucleocytoplasmic rabies virus P protein counteracts Negative Strand RNA Viruses II NII009
France interferon response signaling by inhibiting both nuclear
accumulation and
DNA binding of
STAT1
viro00608 * Adriane Marschalek (1), Stefan Finke (2), Martin Schwemmle (3), Daniel Mayer (3), Bernd Heimrich (3), Lothar Stitz (4), Karl- (1) MvP, LMU Munich, Germany; (2) FLI, Insel Riems, Germany; (3) ALU, Freiburg, Germany; (4) FLI, Tübingen, Germany Attenuation of rabies virus and immune stimulation by IRES-mediated translation of the P protein Negative Strand RNA Viruses II NII010
Klaus Conzelmann (1)
viro00817 * Anne-Sophie Gosselin-Grenet (1), Laurent Roux (1) (1) University of Geneva medical School, Department of Microbiology and molecular medicine, Geneva, Switzerland Sendai virus budding in the course of an infection does not require Alix and VPS4A host factors Negative Strand RNA Viruses II NII011
viro00882 * Ellen Krautkrämer (1), (1) Uniklinikum Hantaviruses enter Negative NII012
Simone Giese (1), Martin Zeier (1) Heidelberg, Nephrologie, Heidelberg, Germany from the apical surface and require DAF Strand RNA Viruses II
viro00924 * Nicole Runkler (1), Stefan Niewiesk (2), Andrea Maisner (1) (1) Institute of Virology, Philipps-University Marburg, Marburg, Germany; (2) Importance of sorting signals in the measles virus wild-type Negative Strand RNA Viruses II NII013
Department of Veterinary Bioscience, The Ohio State University, Columbus, USA glycoproteins for replication in epithelial cells and lymphocytes
viro01072 * Darisuren Anhlan (1), Igor Mazur (1), (1) WWU, Institute of Molecular Virology, Introduction of silent mutations Negative Strand RNA NII014
Christoph Scholtissek (1), Stephan Ludwig (1) Münster, Germany into the nucleoprotein gene Viruses II
influences the
replication of
influenza A viruses
viro01114 * Gülsah Gabriel (1), Astrid Herwig (1), (1) Philipps University Marburg, Institute of Adaptation of the Viral Polymerase to Negative Strand RNA NII015
Hans-Dieter Klenk (1) Virology, Marburg, Germany Importin Alpha Plays a Role in Interspecies Transmission of Viruses II
Influenza Virus
viro01123 Shohreh Mahmoudian (1), Sabrina Auerochs (1) Virological Institute, University Hospital, A cell-based method to quantify Negative Strand RNA NII016
(1), * Manfred Marschall (1) Erlangen, Germany modes of activation or inactivation of the influenza A Viruses II
virus polymerase complex
viro01211 * N. Penski (1), S. Kothlow (2), N. Ruggli (1) University of Freiburg, Freiburg, Role of the NS1 protein of avian Negative Strand RNA NII017
(3), A. Summerfield (3), B. Kaspers (2), J. Stech (4), G. Kochs (1), P. Staeheli (1) Germany; (2) University of Munich, Munich, Germany; (3) IVI, Mittelhäusern, Switzerland; (4) FLI, Riems, Germany influenza A virus strain SC35 (H7N7) in cell culture and in chickens Viruses II
viro01280 * Eva-K. Pauli (1), (1) WWU, Institute of Influenza A virus Negative NII018
Mirco Schmolke (1), Christina Ehrhardt (1), Egbert Flory (2), Carsten Muenk (2), Stephan Ludwig (1) Molecular Virology, Muenster, Germany; (2) PEI, Langen, Germany induced expression of cellular APOBEC3G does not confer antiviral activity Strand RNA Viruses II
viro01284 * Karl Dominik Conrad (1), Kristina Brauburger (1) Philipps University, Institute of Virology, Marburg virus VP24 inhibits viral Negative Strand RNA NII019
(1), Melanie Grosch (1), Elke Mühlberger (1) Marburg, Germany replication Viruses II
viro01322 * Malin Stoltz (1), ClasAhlm (2), Åke Lundkvist (1), Jonas Klingström (1) (1) Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology, Hantavirus infection lead to decreased levels of serum interferon (IFN) - Negative Strand RNA Viruses II NII020
Stockholm, Sweden; (2) Umeå University, Department of Clinical Microbiology, Umeå, Sweden [lambda] in patients, and an established infection is insensitive to IFNs
in vitro
viro01327 * Martina Lobe (1), (1) Marburg University, Inhibition of the Negative NII021
Michael Schümann (1), Elke Mühlberger (1) Institute of Virology, Marburg, Germany Ebola virus polymerase by blocking the binding domain for the polymerase cofactor VP35 Strand RNA Viruses II
viro01382 * Marion Poenisch (1), (1) University of A novel regulatory Negative NII022
Sandra Wille (1), Peter Staeheli (1), Urs Schneider (1) Freiburg, Dept. Virology, Freiburg, Germany sequence affecting viral RNA homeostasis in Borna disease virus Strand RNA Viruses II
infection
viro01394 * Eva Böttcher (1), (1) Philipps University Cleavage of Negative NII023
Tatyana Matrosovich Marburg, Institute of influenza virus Strand RNA
(2), Mikhail Virology, Marburg, hemagglutinin by Viruses II
Matrosovich (2), Germany; (2) NIMR, serine proteases
Michaela Beyerle (1), London, UK HAT and
Hans-Dieter Klenk (1), TMPRSS2 from
Wolfgang Garten (1) human airway
epithelium
viro01397 * Patrick Heinemann (1) Institut für Virologie, The Cytoplasmic Negative NII024
(1), Katrin Schlie (1), Philipps Universität, and Strand RNA
Frank Lennartz (1), Marburg, Germany Transmembrane Viruses II
Wolfgang Garten (1) Domain are
responsible for
correct
Oligomerization of
Lassa Virus
Glycoprotein
Spikes
viro01446 * Anna Överby (1), Ralf (1) Karolinska Institute, The cytoplasmic tail Negative NII025
Pettersson (1), Etienne Neve (1) LICR, Stockholm, Sweden of Uukuniemi virus ([I]Bunyaviridae[/I]) glycoproteins G[SUB]N[/SUB] and Strand RNA Viruses II
G[SUB]C[/SUB] are
important for viral assembly
viro01463 * Kristina Schmidt (1), Sven Enterlein (2), Elke Mühlberger (1) (1) Institute of Virology, Marburg University, Marburg, Germany; (2) USAMRIID, Fort STRUCTURE OF THE MARBURG VIRUS REPLICATION Negative Strand RNA Viruses II NII026
Detrick, MD, USA PROMOTER
viro01595 * Carolin Guenzel (1), (1) Mount Sinai School Recombinant Negative NII027
Megan Shaw (1), Sa Xiao (1), Peter Palese (1) of Medicine, Microbiology, New York City, New York Newcastle disease viruses (rNDV) expressing Nipah virus P, V and W Strand RNA Viruses II
proteins potently downregulate
expression of antiviral genes in human dendritic
cells
viro01647 Wiebke Handke (1), Detlev H. Krüger (1), * Andreas Rang (1) (1) University Hospital Charité, Institute of Virology, Berlin, TLR3-dependent activation of the IFN system by the Negative Strand RNA Viruses II NII028
Germany pathogenic Hantaan virus
viro01670 * Ingeborg van Knippenberg (1), Vincent Leonard (2), Richard Elliott (1) (1) University of St Andrews, Centre for Biomolecular Sciences, St Andrews, United Kingdom; (2) Mayo Shut off of host cell transcription by a viral interferon antagonist. Negative Strand RNA Viruses II NII029
Clinic College of Medicine, Molecular
Medicine Program, Rochester, USA
viro01690 Emma Herrera (1), Patricia Barcenas (1), Guillermo (1) ENCB, IPN, VIROLOGY, DF, MEXICO; (2) ENMyH, A recombinant HN protein from mumps virus Negative Strand RNA Viruses II NII030
Perez_Ishiwara (2), * IPN, BIOMEDICINE, preserves the main
Blanca Barron (1) DF, MEXICO properties of the
complete viral HN
viro01705 * Olivier Reynard (1), Page Audrey (1), Winfried Weissenhorn (1) Inserm U758, Laboratoire des Filovirus, Lyon, Identification of a domain involved in Ebolavirus VP40 Negative Strand RNA Viruses II NII031
(2), Viktor Volchkov (1) FRANCE; (2) Université Joseph Fourier, Grenoble, France binding to plasma membranes
viro01725 * Eva Mittler (1), Jörg Wenigenrath (1), Larissa Kolesnikova (1), Stephan Becker (1) (1) Robert Koch Institute, Berlin, Germany Influence of the Marburg virus glycoprotein cytoplasmic tail on Negative Strand RNA Viruses II NII032
infectivity of viruslike particles
viro01776 Martin Spiegel (1), Katharina Keisers (1), Andrea Thiel (1), Ankur Goyal (1), * Frank Hufert (1) (1) Institut für Virologie, Georg-August-Universität, Göttingen, Germany The NSs protein of Oropouche virus supresses transcription Negative Strand RNA Viruses II NII033
Workshop 18
viro00007 * Adriano Mondini (1), Roberta V M Bronzoni (2), Silvia H P Nunes (2), Francisco Chiaravalloti Neto (1), (1) FAMERP, DESC, S J Rio Preto, Brazil; (2) FAMERP, DDIP, S J Rio Preto, Brazil Phylogenetic and spatial analyses of a dengue outbreak in a medium sized city from Brazil Positive Strand RNA Viruses PSV001
Maurício L Nogueira (2)
viro00037 Radka Komitova (1), * Neli Korsun (2), Petar Petrov (1), Snejana Gurova (2) (1) University Hospital St. Anna, Infectious Diseases Department, Sofia, Bulgaria; (2) National Center of Aseptic Meningitis in Bulgaria 2004 Positive Strand RNA Viruses PSV003
Infectious and Parasitic
Diseases, Sofia,
Bulgaria
viro00428 * Chumporn Soowannayan (1), Jeff Cowley (1), Roger Pearson (1), Tristan (1) CSIRO Livestock Industries, Brisbane, Australia; (2) QIMR, Royal Brisbane Glycans attached to the gp116 and gp64 envelope proteins of yellow Positive Strand RNA Viruses PSV004
Wallis (2), Jeffrey Gorman (2), Wojtek Michalski (3), Peter Walker (3) Hospital, Brisbane, Australia; (3) CSIRO Livestock Industries, AAHL, Geelong, Australia head virus of Penaeus monodon shrimp
viro00430 * Lorena Vega (1), Tsutomu Fujimura (1), (1) Institute of Biochemical Cis-acting signals that affects the Positive Strand RNA PSV005
Rosa Esteban (1) Microbiology (CSIC-University of Salamanca), Salamanca, Spain replication and ribonucleoprotein complexes formation in the 20S RNA Viruses
narnavirus of S.
cerevisiae
viro00450 * Sabine Diedrich (1), Bernd Vollnberg (1), Eckart Schreier (1) (1) Robert Koch Institute, Berlin, Germany Long term shedding of Vaccine derived Poliovirus Type 1 in a German patient Positive Strand RNA Viruses PSV006
viro00492 * Michel de Vries (1), Krzysztof Pyrc (1), Ron Berkhout (2), Wilma Vermeulen-Oost (2), (1) AMC, Medical microbiology, Amsterdam, The Netherlands; (2) VIDISCA as typing technique for picornaviruses Positive Strand RNA Viruses PSV007
Ronald Dijkman (1), Maarten Jebbink (1), Sylvia Bruisten (2), Ben Berkhout (2), Paul Gruteke (2), Lia van der Hoek (1) Municipal Health Service, Public Health laboratory, Amsterdam, The Netherlands
viro00527 * Kwai Peng Chan (1), (1) Singapore General Performance of 2 Positive PSV008
Xin Lai Bai (1), Siew Hoon Lim (1) Hospital, Singapore, Singapore new dengue antigen assays for early dengue diagnosis Strand RNA Viruses
viro00595 Teemu Smura (1), Soile Blomqvist (1), Anja Paananen (1), * (1) National Public Health Institute, Helsinki, Finland NEW INSIGHT INTO EVOLUTION OF THE 5\'UTR OF Positive Strand RNA Viruses PSV009
Tapani Hovi (1), Merja Roivainen (1) ENTEROVIRUS GENOME
viro00613 * Deborah Basso (1), Heinz-Jürgen Thiel (1), Norbert Tautz (1) (1) Universität Gießen, Institut für Virologie, Gießen, Germany Essential role of a host factor for the replication of certain pestivirus strains Positive Strand RNA Viruses PSV010
viro00669 * Tobias Hertzig (1), (1) Queen’s University Coronavirus Positive PSV011
John Ziebuhr (1) Belfast, School of Biomedical Sciences, Belfast, United Kingdom ORF1b-encoded enzymes: proteolytic release and functions in Strand RNA Viruses
viral replication
viro00681 * Sabrina Schrauf (1), Christian W. Mandl (1) (1) Medical University of Vienna, Clinical Institute TBEV NS2B/3 protease uses one Positive Strand RNA PSV012
of Virology, Vienna, Austria of two putative cleavage sites at the C-terminus of Viruses
capsid protein
viro00688 Shui-Mei Wang (1), Yu-Fen Chang (1), * Chin-Tien Wang (1) (1) National Yang-Ming University School of Medicine, Institute of Putative Dimerization Domain of Severe Positive Strand RNA Viruses PSV013
Clinical Medicine, Taipei, Taiwan Acute Respiratory Syndrome Coronavirus
Nucleocapsid Protein Confers
Ability to Efficiently
Package Human APOBEC3G when
Substituted for the
Human
Immunodeficiency Virus Nucleocapsid
Domain
viro00691 * Hitoshi Horie (1), Yuichi Fujii (1), Kouji Katabami (1), Masanori Iwama (1), Akira Yamada (2) (1) Ohu University, School of Pharmaceutical Sciences, Fukushima, Japan; (2) University of Shiga Prefecture, Characterisation of vaccine-derived polioviruses in Japan and an attempt to control the reversion of Positive Strand RNA Viruses PSV014
Department of Human polio vaccine
Nursing, Shiga, Japan viruses to
neurovirulent
genotype
viro00750 * Paula Andreia Silva (1), Sabine Diedrich (1) Robert Koch Institute, Berlin, Identification of enterovirus Positive Strand RNA PSV015
(1), Divina Cardoso (2), Eckart Schreier (1) Germany; (2) Universidade Federal de Goiás, Human serotypes by pyrosequencing Viruses
Virology, Goiânia, Brazil
viro00761 * Caroline Lüken (1), Hermann Müller (1) (1) Institute for Virology, Faculty of Veterinary Medicine, Leipzig, Generation of a Variant E/ Cu-1 reassortant virus of Positive Strand RNA Viruses PSV016
Germany the infectious bursal disease
virus and its
investigation in vitro
viro00789 * Monira Noor (1), Mohammad Rafiqul Islam (1), Priya Mohan (1) Faculty of Veterinary Science, Pathology, Mymensingh, Development of infectious bursal disease virus Positive Strand RNA Viruses PSV017
Das (1), Caroline Lüken (2), Hermann Müller (2) Bangladesh; (2) Virology, Faculty of Veterinary Medicine, Leipzig, Germany vaccine candidates by reverse genetics
viro00851 * Valentina Tefanova (1), Tatjana Tallo (1), Ljudmilla Priimägi (1) (1) National Institute for Health Development, Virology, Tallinn, Trends in the epidemiology of hepatitis A infection Positive Strand RNA Viruses PSV018
Estonia in Estonia
viro01019 * Joern Klein (1), Preben Normann (1), Manzoor Hussain (2), Munir Ahmad (2), Soren Alexandersen (1) (1) National Veterinary Institute, Technical University of Denmark, Virology, Kalvehave, Denmark; (2) FAO, Islamabad, Pakistan Genetic characterisation of the recent foot-and-mouth disease virus subtype A/IRN/2005 Positive Strand RNA Viruses PSV019
viro01026 * Petri Susi (1), Outi (1) University of Turku, Sequence variation Positive PSV020
Lipiäinen (1), Anna Niinimäki (1), Sasu Järvinen (1), Merja Roivainen (2), Timo Hyypiä (1) Virology, Turku, Finland; (2) National Public Health Institute, Enterovirus Laboratory, Helsinki, Finland of Coxsackievirus A7 strains of Human enterovirus A species Strand RNA Viruses
viro01028 * Anil Kumar (1), Sven Miller (1), Ralf (1) University of Heidelberg, Department Characterization of Nuclear Localized Positive Strand RNA PSV021
Bartenschlager (1), Sandra Buehler (1) of Molecular Virology, Heidelberg, Germany NS5 of Dengue Virus Viruses
viro01133 * Anna Jackova (1), Michaela Novackova (1), Mariana Kolesarova (2), Viviane Benetka (3), Dieter (1) University of Veterinary Medicine, Kosice, Slovakia; (2) UPJS, Kosice, Slovakia; (3) University of Bovine coronavirus: Analysis of S1 subunit of isolates originating from Austria and Positive Strand RNA Viruses PSV022
Klein (3), Karin Mostl (3), Stefan Vilcek (1) Veterinary Medicine, Vienna, Austria Slovakia
viro01202 * Vera Schregel (1), Beate Kümmerer (2), Romy Kerber (2), Norbert Tautz (1) (1) Universität Gießen, Institut für Virologie, Gießen, Germany; (2) Bernhard-Nocht-Institut für Tropenmedizin, Overexpression of a host-cell factor inhibits yellow fever virus RNA replication Positive Strand RNA Viruses PSV023
Abteilung für Virologie, Hamburg, Germany
viro01203 * Iris Stallkamp (1), (1) JLU Giessen, Institut Mapping of Positive PSV024
Svenja Wiese (1), für Virologie, Giessen, mutations for Strand RNA
Heinz-Jürgen Thiel (1) Germany differentiation of Viruses
highly virulent
FCoV from its
harmless biotype
viro01250 * Rui Galão (1), Ashwin Chari (2), Antonio Mas (1) University Pompeu Fabra, Barcelona, Cellular LSm1-7 complex required Positive Strand RNA PSV025
(3), Utz Fischer (2), Juana Díez (1) Spain; (2) Biozentrum, Würzburg, Germany; (3) University Castilla-La Mancha, Albacete, Spain for Brome Mosaic Virus RNA translation and replication directly binds to essential RNA translation Viruses
and replication signals
viro01308 * K. Wolthers (1), K. Benschop (1), J. Schinkel (1), R. Molenkamp (1), X. Thomas (1), I. (1) AMC, Medical Microbiology, Amsterdam, The Netherlands; (2) OLVG, Medical Microbiology, Importance of human parechoviruses as a cause for sepsis/meningitis in Positive Strand RNA Viruses PSV026
Spijkerman (2), H. Kraakman (3), D. Pajkrt (4) Amsterdam, The Netherlands; (3) OLVG, Pediatrics, Amsterdam, The Netherlands; (4) Emma Children´s infants
Hospital, Pediatric
Infectious Diseases,
Amsterdam, The
Netherlands
viro01333 * Daniel Ruzek (1), Vlasta Danielova (2), Jaroslava Holubova (2), Jan Kopecky (1), (1) University of South Bohemia and Academy of Sciences of the Czech Republic, Molecular evolution of tick-borne encephalitis virus in the Central Europe Positive Strand RNA Viruses PSV027
Libor Grubhoffer (1) Faculty of Science and Institute of Parasitology, Ceske Budejovice, Czech Republic; (2) National Institute of over 50 years
Public Health, Centre of
Epidemiology and Microbiology, Prague, Czech Republic
viro01428 * Hervé Moulin (1), Torsten Seuberlich (1), Oliver Bauhofer (1), Lea Bennett (1), Jon- (1) Institute of Virology and Immunoprophylaxis, Mittelhäusern, Nonstructural proteins NS2-3 and NS4A of classical swine fever virus: Positive Strand RNA Viruses PSV028
Duri Tratschin (1), Martin A. Hofmann (1), Nicolas Ruggli (1) Switzerland essential features for infectious particle formation
viro01469 Sami Oikarinen (1), * Sisko Tauriainen (1), Didier Hober (2), Bernadette Lucas (2), (1) University of Tampere, Department of Virology, Tampere, Finland; (2) University Enterovirus prevalence in different European populations Positive Strand RNA Viruses PSV029
Peter Muir (3), Lisa Brown (3), Keith Taylor (4), Glyn Stanway (5), Cigdem Williams (5), Christos Bartsocas (6), Andriani Vazeou (6), hospital, Lille, France; (3) Kings College, London, UK; (4) Queen Mary &Westfield College, London, UK; (5) University of Essex,
Evangelos Bozas (6), Maria Dokopoulou (6), Johnny Ludvigsson (7), Colchester, UK; (6) National University, Athens, Greece; (7)
Heikki Hyöty (1) Linköping University,
Lindköping, Sweden
viro01479 * K Benschop (1), C Williams (2), G Pollakis (1), J Schinkel (1), K (1) Academic Medical Center, Medical Microbiology, Recombination evidence within the Human Positive Strand RNA Viruses PSV030
Wolthers (1), G Stanway (2) Amsterdam, The Netherlands; (2) University of Essex, Biological Science, Colchester, United Parechovirus group
Kingdom
viro01543 * Judy Mitchell (1), Kai- (1) The Royal Development of a Positive PSV031
Biu Shiu (1), Harriet Brooks (1), Joe Brownlie (1), Kerstin Erles (1) Veterinary College, PID, Hatfield, United Kingdom quantitative realtime PCR for the detection of canine respiratory coronavirus Strand RNA Viruses
viro01551 * German Tapia (1), Ondrej Cinek (2), (1) Norwegian Institute of Public Health, Oslo, Longitudinal observation of Positive Strand RNA PSV032
Kjersti S. Ronnigen (1), Bjorn Grinde (1) Norway; (2) University Hospital Motol, Prague, The Czech Republic Parechovirus in Norwegian Infants Viruses
viro01575 * C. Claus (1), W.-P. Tzeng (2), T. K. Frey (2), J. Hofmann (1), K.Überla (3), U. G. (1) University of Leipzig, Leipzig, Germany; (2) Georgia State University, Atlanta, Defining important functions of rubella virus structural proteins in virus Positive Strand RNA Viruses PSV033
Liebert (1) USA; (3) Ruhr University Bochum, Bochum, Germany entry and replication
viro01600 * Xin Lai Bai (1), Kwai Peng Chan (1), Siew Hoon Lim (1) (1) Singapore General Hospital, Singapore, Singapore Evaluation of six immunoassays for the detection of Rubella virus- Positive Strand RNA Viruses PSV034
specific immunoglobulin M antibodies
viro01601 * Xin Lai Bai (1), Kwai Peng Chan (1), Siew Hoon Lim (1) (1) Singapore General Hospital, Singapore, Singapore Diagnosis of dengue virus infection: Performance of Positive Strand RNA Viruses PSV035
Panbio Dengue antigen and IgM and IgG antibody
assays
viro01642 * Violaine Olivier (1), Philippe Blanchard (1), Frank Schurr (1), (1) Agence Francaise de Sécurité Sanitaire des Aliments, sophia Molecular Characterization and Phylogenetic Positive Strand RNA Viruses PSV036
Olivier Celle (1), Magali Ribière (1), Richard Thièry (1) antipolis, France Analysis of Chronic Bee Paralysis Virus, a Honey Bee Virus
viro01658 * Alessio Lorusso (1), Bert Jan Haijema (2), Nicola Decaro (1), (1) Faculty of Veterinary Medicine, Animal Health and Well-being, Identification and biochemical characterisation of Positive Strand RNA Viruses PSV037
Pepijn Schellen (2), Canio Buonavoglia (1), Raoul J. de Groot (2) Bari, Italy; (2) , Faculty of Veterinary Medicine, Infectious and Immunology, Utrecht, The Netherlands a novel protein unique to canine coronavirus type I
viro01682 * J. M. Bible (1), P. (1) Guy’s and St. Molecular Positive PSV038
Pantelidis (2), J. W. A. Bendig (3), P. Earl (3), C. Y. W. Tong (1) Thomas’ NHS Foundation Trust, Infection and Immunology, London, epidemiology of Enterovirus 71 (EV71) infection in the UK 1998-2006 Strand RNA Viruses
UK; (2) National Heart and Lung Institute, Imperial College,, Dept of Population Genetics & Gene Therapy, London, UK; (3)
Westpark Hospital, Dept of Microbiology, Epsom, Surrey, UK
viro01688 * Majid Laassri (1), Kathleen Lottenbach (1) Food and Drug Administration, CBER, Effect of different vaccination Positive Strand RNA PSV039
(2), Robert Belshe (2), Stanley Plotkin (3), Bethesda, USA; (2) Saint Louis University, schedules on the excretion and Viruses
Konstantin Chumakov (1) Saint Louis, USA; (3) University of Pennsylvania and Aventis Pasteur, reversion of attenuated poliovirus
Doylestown, USA
viro01698 * Albrecht von Brunn (1), Carola Teepe (1), (1) Max-von-Pettenkofer Institut, Analysis of Intraviral Protein- Positive Strand RNA PSV040
Caroline Friedel (2), Ralf Zimmer (2), Jeremy Simpson (3), Rainer Pepperkok (3), Rhonda Roberts (4), Ralph Baric (4), Jürgen Virology, München, Germany; (2) LMU, Institut für Informatik, München, Germany; (3) EMBL, Heidelberg, Germany; (4) University Protein Interactions of the SARS Coronavirus ORFeome Viruses
Haas (1) of North Carolina, Chapel Hill, USA
viro01716 * Elisabet Witsø (1), Ondrej Cinek (2), Bjørn Grinde (1), Kjersti S. Rønningen (1) (1) Norwegian Institute of Public Health, Oslo, Norway; (2) Motol University Hospital, Prague, The Czech Prevalence and risk factors for enterovirus and adenovirus in stool samples from Positive Strand RNA Viruses PSV041
Republic Norwegian infants
viro01727 C. Juenemann (1), Y. Song (1), G. Bassili (1), D. Goergen (1), J. Henke (1), * M. Niepmann (1) (1) University of Giessen, Institute of Biochemistry, Giessen, Germany Picornavirus Internal ribosomal entry sites can stimulate translation of Positive Strand RNA Viruses PSV042
upstream genes
viro01732 * M. Niepmann (1), J. (1) University of Analysis of the Positive PSV043
Zheng (1) Giessen, Institute of Biochemistry, Giessen, Germany oligomeric state of an RNA-binding protein - a discontinuous Strand RNA Viruses
native protein gel electrophoresis
system
viro01791 * Andreas Kurth (1), Sascha Engel (1), Douglas E Skilling (2), Andreas Nitsche (1), Alvin W Smith (2) (1) Robert Koch-Institut, Centre for Biological Safety, Berlin, Germany; (2) Oregon State University, Laboratory for Zoonotic vesiviruses associated with human hepatitis Positive Strand RNA Viruses PSV044
Calicivirus Studies,
Corvallis OR, USA
viro01862 * Denise Henrych (1), Susanne Lerch (1), Volker Moennig (1), Stefanie Bendfeldt (1), (1) University of Veterinary Medicine Hannover, Institute of Virology, Hannover, Characterization of antigenic domains of the protein E[SUP]rns[/SUP] Positive Strand RNA Viruses PSV045
Irene Greiser-Wilke (1) Germany from Classical swine fever virus
(CSFV) and Bovine viral diarrhea virus
(BVDV)
viro01866 * Farideh Ghazi (1), Bahareh Dabirmanesh (1) Iran University of Medical Sciences, Molecular analysis of proteolytic Positive Strand RNA PSV046
(2), Frooz Sorooshi (1), Glyn Stanway (3) Microbiology, Tehran, Iran; (2) Azahra University, Biochemistry, Tehran, Iran; (3) Essex University, Molecular activity of human Parechovirus type1 2A protein Viruses
Virology, Colchester, UK
Workshop 19
viro00080 * M Kummer (1), NM Turza (1), P Muhl-Zurbes (1), M (1) Univ.Hosp. Erlangen, Dermatology, Erlangen, Germany; (2) HSV-1 Induces CD83 Degradation in mature Dendritic Viral Persistence and Immune VPI001
Lechmann (1), C Boutell (2), RS Coffin (3), RD Everett (2), A Steinkasserer (1), AT Prechtel (1) Univ. Glasgow, MRC Virol., Inst. Virol., Glasgow, UK; (3) Univ.Coll. London, Immunol. Mol. Pathol., London, UK Cells (mDCs) with IE Kinetics via the Cellular Proteasome Evasion
viro00085 J. Eisemann (1), P. (1) Univ. Hosp. Infection of mature Viral VPI002
Muhl-Zurbes (1), A. Steinkasserer (1), * M. Kummer (1) Erlangen, Dermatology, Erlangen, Germany DCs with HSV-1 interferes with the IFN signaling pathway Persistence and Immune Evasion
viro00115 * Katrin Besold (1), Gabriele Hahn (2), Bodo Plachter (1) (1) University of Mainz, Institute of Virology, Mainz, Germany; (2) Impact of HCMV US2-US11-Mediated Immune Viral Persistence and Immune VPI004
LMU Munich, Max von Evasion on MHC Evasion
Pettenkofer Institute, Class I
Munich, Germany Presentation of pp65- and IE1Derived Peptides
viro00435 * Marie-Edith Lafon (1), Muriel Faure-Della (1) University Bordeaux 2, Virology EA2968, Human Cytomegalovirus Viral Persistence VPI005
Corte (1), Noël Magnin (1), Lionel Couzi (2), Julie Dechanet-Merville (3), Pierre Merville (2), Hervé Fleury (1), Isabelle Garrigue (1) Bordeaux, France; (2) University Hospital Bordeaux, Renal Transplantation Unit, Bordeaux, France; (3) University Bordeaux 2, (HCMV) genes natural polymorphism and quasispecies distribution in renal transplant and Immune Evasion
Immunology UMR CNRS 5164 CIRID, recipients
Bordeaux, France
viro00455 * Misael L. Silva (1), Joselma Siqueira-Silva (1), Marcelo Bibancos (1), Fernanda P. Yeda (1) University of Sao Paulo, Microbiologia, Sao Paulo, Brazil Human adenovirus 41 infects lymphocytes Viral Persistence and Immune Evasion VPI006
(1), Charlotte M. Harsi
(1)
viro00543 Maurits de Koning (1), (1) Delft Diagnostic Betapapillomavirus Viral VPI008
Linda Struijk (2), Jan ter Schegget (3), * Mariet Feltkamp (4) Laboratory, Voorburg, The Netherlands; (2) Leiden University Medical Center, Medical es frequently persist in the skin of healthy individuals Persistence and Immune Evasion
Microbiology, Leiden, The Netherlands; (3)
DDL, Voorburg, The Netherlands; (4) LUMC, Leiden, The
Netherlands
viro00786 * Ken Nishimura (1), Mahito Nakanishi (1) (1) National Institute of Advanced Industrial Science and Non-cytopathic Sendai Virus Strain Escapes from Type Viral Persistence and Immune VPI010
Technology, Biotherapeutic Research Laboratory, Tsukuba, Ibaraki, Japan I Interferon Induction by Mutation in L protein Evasion
viro00881 Eva Kolwijck (1), Jolanda Hoefnagel (1), Josje Kingma (2), (1) Radboud University Medical Center, Medical Microbiology, Nijmegen, Virus excretion and immunological markers in the late Viral Persistence and Immune VPI011
Anneke Schoenmaker (3), Willem Melchers (1), * Jochem Galama (1) the Netherlands; (2) Bartiméus, Inst for visual handicapped, Doorn, Netherlands; (3) Viataal, Inst for progression of symptoms in congenital rubella syndrome Evasion
deafness, St
Michielsgestel, Netherlands
viro00884 Gennadiy Zelinskyy (1), Frank Krux (1), * Ulf Dittmer (1) (1) Institute for Virology, Essen, Germany Virus-infected dendritic cells expand CD4+ regulatory T cells during acute Friend Viral Persistence and Immune Evasion VPI012
retrovirus infection
and contribute to
the development of a chronic infection.
viro00914 * Päivi Norja (1), Kati Hokynar (1), Peter Simmonds (2), Maria (1) University of Helsinki, Helsinki, Finland; (2) University Bioportfolio:lifelong tissue persistence of new and old Viral Persistence and Immune VPI013
Söderlund-Venermo (1), Klaus Hedman (3) of Edinburgh, Edinburgh, UK; (3) Helsinki University Central Hospital Laboratory, Helsinki, Finland parvoviruses Evasion
viro01002 * Anna Heinzelmann (1) Georg-Speyer-Haus, APOBEC3G in Viral VPI014
(1), Andreas Meyerhans (2), Ursula Dietrich (1), Hagen von Briesen (3) Frankfurt am Main, Germany; (2) Universität des Saarlandes, Homburg Saar, Germany; (3) Fraunhofer Institut fuer infected myeloid cells as an antiviral target Persistence and Immune Evasion
Biomedizinische
Technik, St. Ingbert, Germany
viro01155 Lev Goldfarb (1), (1) National Institute of Viluisk Viral VPI015
Ekaterina Subbotina Neurological Disorders, encephalomyelitis: Persistence
(2), Evgeniy Savilov (3), Vsevolod Vladimirtsev (4), * Alexander Chepurnov NIH, Bethesda, MD, USA; (2) SRCVB Vector, Novosibirsk, Russia; (3) Institute of an emerging infectious disease and Immune Evasion
(5) epidemiology, Irkutsk, Russia; (4) Institute of Health, Yakutsk,
Russia; (5) Michigan Nanotechnology Institute for Medicine
and Biological Sciences, University of Michigan, Ann Arbor, USA
viro01158 Yu-Tsih Shih (1), * Wei-June Chen (1) (1) Chang Gung University, Public Health and Identification of eukaryotic translation initiation Viral Persistence and Immune VPI016
Parasitology, Kwei-San, Tao-Yuan, TAIWAN factor 5A (eIF5A) and its potential role during dengue 2 virus infection in Evasion
mosquito C6/36 cells
viro01208 * Kerstin Schneider (1), (1) IMH, Virology, Human Viral VPI017
Ursula Meyer-König (1), Frank T. Hufert (2) Freiburg, Germany; (2) Virology, Göttingen, Germany cytomegalovirus impairs the function of plasmacytoid dendritc cells Persistence and Immune Evasion
isolated from tonsil
but not the function
of pDC isolated from blood
viro01230 * Shadi Salloum (1), Cesar Oniangue-Ndza (1), Marc aus dem Siepen (1), Stefan Ross (1), Michael (1) University of Essen, Institute of Virology, Essen, Germany Escape in an HCV CTL epitope exacts fitness costs Viral Persistence and Immune Evasion VPI018
Roggendorf (1), Joerg Timm (1), Sergei Viazov (1)
viro01235 * Bernd Köberlein (1), Axel Zurhausen (2), Ruth Chin (3), Hanswalter Zentgraf (1) Institute of Pathology, Molecular Pathology, Tuebingen, Germany; (2) Suppressor of cytokine signaling-3 (SOCS-3) is induced by Viral Persistence and Immune Evasion VPI019
(4), Reinhard Kandolf (1), Thomas Bock (1) Pathology, Department of Pathology, Freiburg, Germany; (3) Clinical center for research Hepatitis B Virus in HuH7 cells and liver tissue
excellence, Department of Medicine, Melbourne,
Australia; (4) German Cancer Research
Center, Applied Tumorvirology, Heidelberg, Germany
viro01254 * Lorenz Jäger (1), Anja Ehrhardt (1) (1) Max von Pettenkofer Institute, Virology, Gene deleted adenoviral vector Viral Persistence VPI020
Munich, Germany genomes do not form concatemers and Immune Evasion
or circular
monomers:
Implications for
persistence of
recombinant
adenoviral vectors
viro01255 * Antje Knöll (1), Tilo Schlittenbauer (1), Bernd Krüger (2), Bernhard Krämer (2), Wolfgang Jilg (1), Arndt Hartmann (3) (1) University of Regensburg, Medical Microbiology, Regensburg, Germany; (2) University of Regensburg, Internal Frequent BK virus DNA detection in renal allograft recipients Viral Persistence and Immune Evasion VPI021
Medicine, Regensburg, Germany; (3) University of Regensburg, Pathology, Regensburg, Germany
viro01260 Caroline Staib (1), * Simone Backes (1), (1) GSF - TU München, Institut f. Virologie, C7L host range gene is essential Viral Persistence VPI022
Karin Sperling (2), Gerd Sutter (2) München, Germany; (2) Paul Ehrlich Institut, Abteilung f. Virologie, Langen, Gerermany for vaccinia virus MVA life cycle in human and murine cells and Immune Evasion
viro01315 * Katja Maurer (1), Ellen Harrer (1), Andreas Goldwich (2), (1) University of Erlangen-Nuremberg, Department of Medicine Analysis of CTL mediated immune selection in a Viral Persistence and Immune VPI023
Kathrin Eismann (1), Birgit Schätz (1), Sandra Müller (1), Silke Bergmann (1), Thomas Harrer (1) III Immunology, Erlangen, Germany; (2) University of Erlangen-Nuremberg, Clinical and Molecular Virology, Erlangen, Nuermberg dominant HLA B8restricted CTL Epitope in Nef Evasion
viro01392 * Markus Lantermann (1) Paul-Ehrlich-Institut, Vaccinia virus Viral VPI024
(1), Astrid Schwantes (1), Katja Sliva (1), Gerd Sutter (1), Barbara Schnierle (1) Virology, Langen, Germany double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated Persistence and Immune Evasion
gene silencing in
mammalian cells
viro01471 * Andreas Busche (1), Andre Bleich (2), Corinna Benkartek (1), Martin Messerle (1) (1) Medical School Hannover, Institute of Virology, Hannover, Germany; (2) Medical School Hannover, AN MCMV IE1 DELETION MUTANT ESTABLISHES AND Viral Persistence and Immune Evasion VPI025
Institute of Laboratory REACTIVATES
Animal Science, FROM LATENCY
Hannover, Germany
viro01544 * Eva Gellermann (1), Wiebke Albrecht (1), Abel Viejo-Borbolla (1), Thomas F. Schulz (1) (1) Hanover Medical School, Institute of Virology, Hanover, Germany Interaction of KSHV LANA with USP7: Implications for p53 function Viral Persistence and Immune Evasion VPI026
viro01568 * Mathias Thurau (1), Gaby Sander (1), (1) Clinical Center, University of Erlangen, K13 of Human Herpesvirus Type-8 Viral Persistence VPI027
Kristina Weinländer (1), Elisabeth Naschberger (1), Khaled Alkharsah (2), Thomas Schulz (2), Michael Stürzl (1) Division for Molecular and Experimental Surgery, Erlangen, Germany; (2) Hannover Medical School, Institute of Virology, Protects Against Superoxide-Induced Cell Death and Immune Evasion
Hannover, Germany
viro01589 Avis Dafa-Berger (1), Slava Rom (1), Tracey Baas (2), Bryan Paeper (2), Sean Proll (2), (1) Ben Gurion Univ, Microbiology and Immunology, Beer Sheva, Israel; (2) Using functional genomics to unravel the governing Viral Persistence and Immune Evasion VPI028
Michael Katze (2), * Bracha Rager-Zisman (1) University of Washington, Microbiolgy, Seattle, USA mechanisms of persistent virus infection
viro01630 * Cindy Gutzeit (1), Martin J. Raftery (1), Thomas Giese (2), (1) Charite Medical School, Institute of Virology, Berlin, Interference of Varicella-Zoster Virus strains with Viral Persistence and Immune VPI029
Craig Morita (3), Guenther Schoenrich (1) Germany; (2) University of Heidelberg, Institute of Immunology, Heidelberg, Germany; (3) University of Iowa, Department of Internal the CD1 antigen presenting system in immature Dendritic Cells Evasion
Medicine, Iowa, USA
viro01748 * Michael Kleines (1), Simone Scheithauer (1), Martin Häusler (2) (1) UK Aachen, Virology, Aachen, Germany; (2) UK Aachen, Pediatrics, MHV-68 infection of mice: an animal model of human cardiac disease Viral Persistence and Immune Evasion VPI031
Aachen, Germany related to EBV infection
viro01777 * Martin Raftery (1), (1) Institute of Virology, Human Viral VPI032
Günther Schönrich (1) Charite Campus Mitte, Berlin, Germany Cytomegalovirus interference in CD1 antigen presentation Persistence and Immune Evasion
viro01780 * Martin Raftery (1), Elisabeth MönckeBuchner (1), Hideo (1) Institute of Virology, Charite Campus Mitte, Berlin, Germany; (2) Unravelling the interaction of HCMV with Viral Persistence and Immune VPI033
Matsumura (2), Thomas Giese (3), Monika Reuter (1), Ryohei Terauchi (2), Günther Schönrich (1), Detlev Krüger (1) Iwate Biotechnology Research Center, Kitakami, Japan; (3) Institute of Immunology, University of Heidelberg, Heidelberg, dendritic cells using SuperSAGE Evasion
Germany
viro01871 * Tsan Yuk Lam (1), Frederick, Chi-Ching Leung (1) (1) The University of Hong Kong, Department of Zoology, Hong Kong, Hong Kong, China Different modes of viral persistence of highly pathogenic avian influenza (HPAI) and low pathogenic avian Viral Persistence and Immune Evasion VPI034
influenza (LPAI) viruses revealed by their evolutions
viro01877 Jurica Arapovic (1), Tihana Lenac (1), * Marina Babic (1), Ronald Antulov (1), (1) Medical faculty, Histology and Embryology, Rijeka, Croatia Resistance of RAE-1[delta] to downmodulation by MCMV Viral Persistence and Immune Evasion VPI035
Astrid Krmpotic (1), Bojan Polic (1), Stipan Jonjic (1)
viro01887 * Tobias Keßler (1), Michael Reich (2), Eva Tolosa (3), Christoph Driessen (2), Klaus (1) Medical Virology, Tübingen, Germany; (2) Medicine II, Tübingen, Germany; (3) Hertie HCMV interferes with the antigen presentation pathways in Viral Persistence and Immune Evasion VPI036
Hamprecht (1), Institute for Clinical dendritic cells at
Gerhard Jahn (1) Brain Research, multiple levels
Tübingen, Germany
Workshop 20
viro00015 * Keivan Zandi (1), (1) Bushehr University Antiherpetic activity Antivirals and AVR001
Maryam Salimi (1), Kohzad Sartavi (2) of Medical Sciences, Persian Gulf Health Research Center, Bushehr, Iran; (2) Jahad-Keshavarzi of the red marine alga from Persian gulf, Gracilaria salicornia Resistance
Research Center,
Botany, Bushehr, Iran
viro00118 * Martin Michaelis (1), Anh Ha (1), Hans Wilhelm Doerr (1), Jindrich Cinatl (1) (1) Klinikum d. J. W. Goethe-Universität, Institut für Medizinische Virologie, Frankfurt am Main, Germany Valproic acid stimulates human cytomegalovirus replication in endothelial cells Antivirals and Resistance AVR002
viro00473 * Tatiana Betakova (1), Katarina Balintova (2), (1) Institute of Virology, Bratislava, Slovak Preparation of recombinant Antivirals and Resistance AVR003
Anna Ohradanova (1), Peter Kabat (2) Republic; (2) Comenius University, Department of Microbiology and Virology, Bratislava, Slovak Republic human interferon [lambda]1 and analysis of its antiviral activities against influenza and vaccinia
viruses
viro00495 * M. I. Alam (1), H. Marjuki (2), C. Erhardt (3), O. Planz (4), S. Ludwig (3), S. Pleschka (1) (1) Justus-Liebig-University, Institute for Medical Virology, Giessen, Germany; (2) St. Jude Children´s Res. Hospital, Inhibitory Action of Verapamil on Influenza A Virus Replication Antivirals and Resistance AVR004
Department of Infectious Diseases,
Memphis, USA; (3) University Muenster, Institute for Molecular
Virology, Münster,
Germany; (4) Freidrich-Loeffler-Institute,
Institute for
Immunology, Tübingen, Germany
viro00607 * Andreas Kurth (1), Anna Dunkhorst (1), (1) RKI, ZBS1, Berlin, Germany; (2) Charité, DNA Aptamers impair Antivirals and Resistance AVR005
Doreen Muth (1), Andreas Kage (2), Andreas Nitsche (1) Laboratory Medicine, Berlin, Germany Orthopoxvirus Infection
viro00656 * Jiraporn Nikomtat (1), Yingmanee Tragoolpua (2) (1) Chiang Mai University, Biotechnology, Graduate School, Anti-Herpes Simplex Virus Type 2 activities from [I]Inula cappa[/I] Antivirals and Resistance AVR006
Chiang Mai, Thailand; (2) Chiang Mai University, Biology, Chiang Mai, Thailand (Ham.ex D.Don)DC. and [I]Cissus rependa[/I] Vahl. Extracts
viro00663 * Raenu Yucharoen (1) Chiang Mai Efficacy of Anti- Antivirals and AVR007
(1), Yingmanee University, HSV-1 Activity of Resistance
Tragoolpua (2) Biotechnology, Graduate School, Chiang Mai, Thailand; (2) Chiang Mai Some Thai Highland Plants
University, Biology, Chiang Mai, Thailand
viro00715 * Keivan Zandi (1), Parisa Pakdel (1), Kohzad Sartavi (2) (1) Bushehr University of Medical Sciences, Persian Gulf Health Research Center, Bushehr, Iran; (2) Antiviral activity of a brown alga from Persian gulf,Cystoseira myrica against Antivirals and Resistance AVR008
Jahad-Keshavarzi Research Center, Botany, Bushehr, Iran herpes simplex virus type 1 in cell culture
viro00731 * J. Muench (1), L. Staendker (2), K. Adermann (3), A. Schulz (2), M. (1) Institute of Virology, University of Ulm, Ulm, Germany; (2) IPF PharmaCeuticals Discovery of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Antivirals and Resistance AVR009
Schindler (1), R. Chinnadurai (1), S. Poehlmann (4), C. Chaipan (4), T. Biet (5), T. Peters (5), B. Meyer (6), D. Wilhelm (6), H. GmbH, Hannover, Germany; (3) VIRO Pharmaceuticals GmbH & Co. KG, Hannover, Germany; (4) University of Erlangen-Nuernberg, Peptide
Lu (7), W. Jing (7), S. Jiang (7), W.-G. Forssmann (8), F. Kirchhoff (1) Erlangen, Germany; (5) University of Luebeck, Luebeck, Germany; (6) University of Hamburg, Hamburg, Germany; (7) Lindsley F. Kimball
Research Institute, New
York, USA; (8) Center of Pharmacology, Hannover Medical
School, Hannover,
Germany
viro00811 * Susanne Duwe (1), (1) Robert Koch-Institut, Incidence of drug Antivirals and AVR010
Thorsten Wolff (1), Brunhilde Schweiger (1) Berlin, Germany resistant influenza A viruses in Germany Resistance
viro00865 * Jae-Seon Hwang (1), Oliver Kregler (1), John C. Drach (2), Leroy B. Townsend (3), Rita (1) Institute of Virology, Charité Universtiy Hospital, Berlin, Germany; (2) New benzimidazole D-ribonucleosides inhibit viral DNA replication Antivirals and Resistance AVR011
Schilf (1), Elke Bogner (1) Department of Biologic and Materials Sciences, School of Dentistry, Ann Arbor, USA; (3) Interdepartmental Graduate Program in
Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, USA
viro00894 Stefanie Thulke (1), Ivonne Naumann (2), Rainer Buchholz (2), * (1) Charité-CCM, Onko/Häma, Berlin, Gemany; (2) FAU, BVT, SQDGs – potential antiviral agents? Antivirals and Resistance AVR012
Aleksandar Randonic (1), Wolfgang Siegert (1), Harald Lange (2), Erlangen, Germany
Christian Walter (2)
viro00904 * Alexandra Nordmann (1) Philipps University Antiviral Potential Antivirals and AVR013
(1), David Stein (2), Hans-Dieter Klenk (1), Gülsah Gabriel (1) Marburg, Institute of Virology, Marburg, Germany; (2) Avi BioPharma Inc., of Morpholino Oligomers Targeting NP and PB1 Genes of Resistance
Corvallis, Oregon, United States of Influenza A Virus
America
viro00960 * Marcel Jonges (1), Mariken van der Lubben (1), Pieter Overduin (1), Adam Meijer (1) (1) National Institute for Public Health and the Environment, Laboratory for Infectious Diseases and Screening, Bilthoven, Antiviral susceptibility of Dutch seasonal influenza viruses Antivirals and Resistance AVR014
NLD
viro00968 * Hans Josef Schramm (1), Wolfgang Schramm (1) (1) LMU, Hemostaseology, München, Germany Interface targeting peptides as inhibitors of HIV Antivirals and Resistance AVR015
protease – an update
viro00986 * A. Stankiewicz-Drogon (1), V. Kostina (1) Institute of Biochemistry and Acridone derivatives as Antivirals and Resistance AVR016
(2), L. Palchykovska (2), A. Alexeeva (2), A.D. Shved (2), A.M. Boguszewska-Chachulska (1) Biophysics PAS, Warsaw, Poland; (2) Institute of Molecular Biology and Genetics NAS, Kiev, Ukraine potential anti-HCV agents
viro00990 * Koen Janssens (1), Bruno Pot (1), Luc (1) Applied Maths NV, Sint-Martens-Latem, An open HIV Drug Resistance Antivirals and Resistance AVR017
Vauterin (1), Paul Vauterin (1) Belgium [I]Expert Rule System[/I] in the BioNumerics®
software
viro01066 * Ingrid Hülsmeyer (1), Stephan Kremb (2), Horst Wolff (2), Dieter (1) GSF, Immune Monitoring Unit, Munich, Germany; (2) Detection of cellassociated early HIV gene Antivirals and Resistance AVR018
Hoffmann (3), Hermann Schätzl (3), Ruth Brack-Werner (2) GSF, IMV, Neuherberg, Germany; (3) TUM, Institut für Virologie, Munich, Germany expression on single cell level
viro01069 * Beatrice Mercorelli (1), Giulia Muratore (1), Elisa Sinigalia (1), (1) Univ Padova, Dept Histol, Microbiol & Med Biotech, Padova, Italy; A new 6aminoquinolone, WC5, with specific Antivirals and Resistance AVR019
Maria A Biasolo (1), Oriana Tabarrini (2), Violetta Cecchetti (2), Arianna Loregian (1), Giorgio Palù (1) (2) Univ Perugia, Dept.Chem & Technol Drugs, Perugia, Italy anti-HCMV activity
viro01136 * Martin Obermeier (1), Raymund Buhmann (1) Max von Pettenkofer Institut, Virology, Oligonucleotide based drug Antivirals and Resistance AVR020
(2), Gundula Jäger (1) Munich, Germany; (2) LMU, Medicine III, Munich, Germany reduces activity of acyclovir (ACV) against HSV
viro01140 * Martin Obermeier (1), Hans Nitschko (1), Josef Eberle (1), Gundula Jäger (1) (1) Max von Pettenkofer Institut, Virology, Munich, Germany Fully automated analysis of Hepatitis B Sequences for interpretation of Antivirals and Resistance AVR021
drug resistance and
HBs-antigen
escape mutations
viro01165 * Svetlana Rak (1), Elena Goncharova (1), Ilya Vinogradov (2), (1) SRC VB Vector, Vaccines and Antivirals, Koltsovo, Russia; (2) Virucidal properties of low-molecular polyvalent inhibitor Antivirals and Resistance AVR022
Elena Ryabchikova (2), Alexander Ryzhikov (1) SRC VB Vector, Microscopy, Koltsovo, Russia of influenza virus hemagglutinin
viro01244 Christina Ehrhardt (1), * Eike R Hrincius (1), Virginia Korte (1), Igor Mazur (1), Karoline (1) Institute for Molecular Virology, WWU, Münster, Germany; (2) FLI, CYSTUS052, a polyphenol rich plant extract, exerts potent anti- Antivirals and Resistance AVR023
Droebner (2), Anne Pötter (3), Mirco Schmolke (1), Oliver Planz (2), Stephan Ludwig (1) Tübingen, Germany; (3) Dr. Pandalis Naturprodukte GmbH, Glandorf, Germany influenza virus activity in cell culture
viro01276 * A. Hahn (1), J. Geiler (1), P. Nazck (1), M. (1) Institut für Medizinische Virologie, Glycyrrhizin for the Treatment of Highly Antivirals and Resistance AVR024
Michaelis (1), H. W. Doerr (1), J. Cinatl Jr. (1) Universitätsklinikum, Frankfurt/Main, Germany Pathogenic Influenza H5N1 Infection
viro01281 * Woo-Young Choi (1), Min-Ji Kim (1), Nam-Joo Lee (1), Hyun-Jung Ju (1), Joo-Yeon Lee (1) Korean CDC, Div.of Influenza & Respiratory Viruses, Seoul, Republic of Korea Monitoring of Amantadine Resistant Influenza A Korean Isolates Antivirals and Resistance AVR025
(1), Hee-Bok Oh (1), Hae-Wol Cho (1), Chun Kang (1) by Pyrosequencing
viro01307 * Stanislav Markushin (1), Sergey Artyushenko (1), Nikholai Kontarov (1), (1) Mechnikov Research Institute for Vaccines and Sera, virology, Moscow, Mechanisms of antiviral effect of a boroadamantane derivative BG-12 Antivirals and Resistance AVR026
Yuri Bubnov (2) Russia; (2) Zelinsky Research Institute of
Organic Chemistry, Moscow, Russia
viro01367 M Sturmer (1), P Gute (2), S Klauke (3), S Staszewski (1), * HW (1) JWG-Univ. Hosp., FFM, Ger; (2) HIV SP, FFM, Ger; (3) IFS, Subtype-Dependent Increase of Drug Antivirals and Resistance AVR027
Doerr (1), P Lecocq (4), M Van Houtte (4) FFM, Ger; (4) Virco BVBA, Mechelen, Bel Resistance Score for Tipranavir in PInaïve HIV-1
Infected Patients:
Bias of the
Algorithm or Lower
Genetic Barrier in
Non-B Subtypes?
viro01390 * Anna Maisa (1), Ute Ströher (2), Carolin Weise (1), Wolfgang Garten (1), Thomas Strecker (1) (1) Institute of Virology, Philipps University, Marburg, Germany; (2) NML, Public Health Agency of Canada, Bioengineered [alpha]1-Antitrypsin variants are potential inhibitors for the Lassa virus Antivirals and Resistance AVR028
Winnipeg, Canada glycoprotein activating protease SKI-1/S1P
viro01395 * Melanie Balduin (1), Herbert Pfister (1), Mark Oette (2), Rolf Kaiser (1) (1) Institute of Virology, University, Cologne, Germany; (2) Dept. Gastroenterology, Detection of minorities at reverse transcriptase Antivirals and Resistance AVR029
University, Duesseldorf, K103N of HIV
Germany strains in therapy
naive patients
viro01442 Jan Felix Drexler (1), Luciano Luna (2), (1) Hospital Universitario Prof. Rates and reasons of failure of Antivirals and Resistance AVR030
Eduardo Netto (1), * Christian Drosten (2) Edgard Santos, Salvador, Brazil; (2) Bernhard Nocht commercial HIV-1 viral load assays in Brazil
Institute for Tropical Medicine, Clinical
Virology, Hamburg,
Germany
viro01484 Marco Axmann (1), * Susanne Pfefferle (2), Anna-Winona Struck (1), Christian Drosten (2), Bernd Meyer (1) (1) University of Hamburg, Institute of Organic Chemistry, Hamburg, Germany; (2) Bernhard Nocht Institute for Tropical A hexapeptide that blocks SARS-Coronavirus receptor binding Antivirals and Resistance AVR031
Medicine, Clinical
Virology, Hamburg, Germany
viro01491 * Katharina Göhring (1), Elfriede Mikeler (1), Gerhard Jahn (1), Klaus Hamprecht (1) (1) Institute of Medical Virology, University Hospital of Tuebingen, 72076 Tuebingen, Characterisation of clinical HCMV strains with multiple UL97 and UL54 Antivirals and Resistance AVR032
Germany mutations
viro01556 * Sybille Somogyi (1), Ralitsa Valchanova (1), Stefan Neifer (2), Thomas Berg (2), Frank Schlote (3), Katrin Arndt (1), (1) Robert Koch-Institute, Berlin, Germany; (2) Diagnostic Laboratory, Berlin, Germany; (3) Medical Practice, Berlin, Evolution and persistence of transmitted multiresistant HIV-1 Antivirals and Resistance AVR033
Claudia Kuecherer (1) Germany
viro01586 Nadav Orr (1), Israel Nur (1), Orgad Laub (1), Yitzhak Samina (2), Yevgeni Khimich (2), Ahuva Gottreich (3), Michael Simanov (1) Omrix Pharmaceuticals, MDA Blood Center, Tel Hashomer Hospital, Kiryat Ono, Israel; (2) Veterinary Inst., WNIG for treatment of West Nile infection Antivirals and Resistance AVR034
(2), * Bracha Rager-Zisman (4), David Ben Nathan (4) Virology, Beit Dagan, Israel; (3) MDA Blood Center, Tel Hashomer Hospital, Kiryat Ono, Israel; (4) Ben Gurion University, Microbiology
and Immunology, Beer Sheva, Israel
viro01598 * Julian WT Tang (1), Karry LK Ngai (1), Jianlin Shao (2), Wai Y Lam (1), Sai M Ngai (2), Paul KS Chan (1) (1) The Chinese University of Hong Kong, Microbiology, Hong Kong SAR, China; (2) The Chinese New emerging neuraminidase mutations in Hong Kong influenza A(H3N2) viruses Antivirals and Resistance AVR035
University of Hong Kong, Biology, Hong Kong SAR, China 1997-2006: antigenic drift or drug resistancerelated?
viro01645 * Ksenia Pumpor (1), Koen Verschueren (1), Rolf Hilgenfeld (1) (1) University of Luebeck, Institute of Biochemistry, Lübeck, Crystallography-Driven Inhibitor Design: Preventing Antivirals and Resistance AVR036
Germany Activation of the
SARS-CoV Main
Proteinase
viro01669 Eva Bernhoff (1), Tore J Gutteberg (1), Kjersti Sandvik (1), Hans H (1) University Hospital of North Norway, Microbiology and Effect of Cidofovir on Polyomavirus BK Replication Antivirals and Resistance AVR037
Hirsch (2), * Christine H Rinaldo (1) Infection Control, Tromsø, Norway; (2) University of Basel, Transplantation Virology, Basel, Switzerland
viro01673 * F. G. Hermann (1), S. (1) Georg-Speyer-Haus, In vitro selection of Antivirals and AVR038
Lohrengel (2), M. Dittmar (2), U. Dietrich (1), D. von Laer (1) Frankfurt, Germany; (2) Universität Heidelberg, Heidelberg, Germany HIV-1 with resistance towards the fusion inhibitor maC46 Resistance
viro01714 Maren Eggers (1), * Berit Erbes (2), C. Benzinger (1), Th (1) Labor Enders und Partner, Institute for Virology, Infectiology A novel approach to validate disinfectants Antivirals and Resistance AVR039
Regnath (1), M Enders (1), Stephan Urban (2) und Epidemiology e.V., Stuttgart, Germany; (2) University of Heidelberg, Dept. Mol. Virology, Otto Meyerhof Zentrum, Heidelberg, against human hepatitis B virus using a cell culture system supporting the full replication cycle
Germany
viro01730